Abbott (ABT) Tops Q2 EPS by 16c, FY EPS Guidance Tops Views
Get Alerts ABT Hot Sheet
Price: $105.27 --0%
EPS Growth %: -4.9%
Financial Fact:
Other (income) expense, net: 972M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -4.9%
Financial Fact:
Other (income) expense, net: 972M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $0.57, $0.16 better than the analyst estimate of $0.41. Revenue for the quarter came in at $7.3 billion versus the consensus estimate of $6.75 billion.
GUIDANCE:
Abbott sees FY2020 EPS of at least $3.25, versus the consensus of $2.84.
- Abbott projects full-year 2020 diluted earnings per share from continuing operations under GAAP of at least $2.00. Abbott forecasts specified items for the full-year 2020 of $1.25 primarily related to intangible amortization, acquisition-related expenses, restructuring and cost reduction initiatives and other expenses. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be at least $3.25 for full-year 2020.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott (ABT) Tops Q1 EPS by 2c, Offers Guidance
- Schlumberger Ltd. (SLB) Reports In-Line Q1 EPS
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!